Newsletter

Chulalongkorn is waiting for FDA green light to test ChulaCov19 vaccine in people, expecting to register by the end of the year.

Prof. Dr. Kiat Rakrungtham Executive Director of the COVID-19 Vaccine Development Project Vaccine Research Center Faculty of Medicine Chulalongkorn University and Chulalongkorn Hospital, Thai Red Cross Society, revealed the progress of the ChulaCov19 mRNA vaccine development that, in general, it is good news. The early development was found to be safe. It stimulates the immune […]

“ChulaCov19” was tested in people in phase 2 with good results, stimulating high immunity. Expected to be used in the middle of the year 65

November 18, 2021, Chulalongkorn University Revealing the progress of the covid vaccine of Chulalongkorn University “ChulaCov19” The mRNA vaccine after phase 2 trials in humans was as effective and highly effective as Pfizer. By Prof. Dr. Kiat Rakrungtham Executive Director of the COVID-19 Vaccine Development Project Vaccine Research Center Faculty of Medicine Chulalongkorn University Talk […]

“Covid Vaccine” “ChulaCov19” reveals that it can resist 4 strains.

“Chulalongkorn Hospital” Thai Red Cross Society, Faculty of Medicine Chulalongkorn University and the Vaccine Research Center Faculty of Medicine, Chulalongkorn University announces the test “covid vaccine” “ChulaCOV19“which is a type of vaccine”mRNA“Thai nationality by volunteers who pass the screening that are healthy in Phase 1 reveal that they can resist “Covid-19” Up to 4 species […]

Chulalongkorn doctors inform the good news, test the ‘ChulaCOV19’ vaccine in volunteers to accelerate the next phase of research.

Tuesday, August 17, 2021, 11.14 a.m. August 17, 2021, Chulalongkorn Hospital, Thai Red Cross Society, Faculty of Medicine Chulalongkorn University and the Vaccine Research Center Faculty of Medicine Chulalongkorn University Joint press conference to inform the progress of the vaccination test “ChulaCov19” (Chula-Kov-Nine-Teen) type mRNA of Thai nationality of volunteers who passed the screening phase […]

Good news! ChulaCov-19 vaccine test results are equivalent to Pfizer. It will be used in April 65.

August 16, 2021 reporters reported that Prof. Dr. Kiat Rakrungtham Executive Director of the COVID-19 Vaccine Development Project Vaccine Research Center Faculty of Medicine Chulalongkorn University and Chulalongkorn Hospital, Thai Red Cross Society held a press conference via Facebook Live of Chulalongkorn Hospital, Thai Red Cross Society in case of progress on vaccine research and […]